6 Results for "

anti-rheumatoid

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "anti-rheumatoid" in MCE Product Catalog:

Cat. No.: HY-103046
CAS No.: 2123480-72-6
Purity:  99.84%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology

UbcH5c-IN-1 (compound 6d) is a potent and selective small-molecule inhibitor of Ubiquitin-conjugating enzyme UbcH5c, with a Kd of 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85. A promising lead compound for the development of new antirheumatoid arthritis (RA) agent .
loading...
    loading...
loading...
    loading...
Cat. No.: HY-N11957
CAS No.: 77165-80-1
Angeloylbinankadsurin A (compound 7) is an anti-rheumatoid arthritis (RA) agent that can be isolated from EtOAc and CH2Cl2 extracts of Black Tiger Beard. Angeloylbinankadsurin A exhibits inhibitory activity on RA-FLS cells (IC50=11.70 μM). Angeloylbinankadsurin A is slightly toxic to human cancer cell lines (Hela and BGC-823) (IC50=19.9 μM, 21.93 μM) .
loading...
    loading...
Cat. No.: HY-N20344
Synonyms: Kochia scoparia fruit extract
Category:  

Extract

Target:  

Parasite

Kochiae fructus extract (Kochia scoparia fruit extract) is an extract of Kochia scoparia (L.) Schrad., containing a variety of bioactive components with anti-inflammatory, anti-diabetic, insecticidal, anti-allergic, antipruritic, and anti-rheumatoid arthritis activities.
loading...
    loading...
Cat. No.: HY-N17353
CAS No.: 819861-41-1
Vitedoamine A is a Phenylnaphthalene-type lignan alkaloid. Vitedoamine A can be isolated from Vitex negundo. Vitedoamine A inhibits the activity of IKKβ with an IC50 value of 39 μM. Vitedoamine A could inhibit the transcriptional activity of NF-κB, and suppress the production of NO and reduce the expressions of inflammatory cytokines (IL-1β, IL-6, and TNF-α). Vitedoamine A inhibits the phosphorylation of IKKα/β and p65, and prevents the degradation of IκBα. Vitedoamine A possesses anti-rheumatoid arthritis capacity .
loading...
    loading...
Cat. No.: HY-L210
2,023 compounds

Rheumatoid Arthritis (RA) is a autoimmune disease characterized by persistent joint inflammation. The pathology of RA includes immune cell infiltration, synovial lining proliferation, pannus formation, and the destruction of joint cartilage and bone, which is highly disabling. Due to long-term chronic inflammation, RA not only severely affects the quality of life of patients but can also damage multiple organs, leading to lung diseases, cardiovascular diseases, and malignant tumors. The pathogenesis of RA is complex, involving genetic, environmental, and immune factors. With the advancement of high-throughput screening technology, screening for compounds targeting JAK, CCR, MEK, MMP targets may contribute to the development of more effective drugs against Rheumatoid Arthritis (RA).

MCE has collected 2,023 small molecule compounds with definite or potential anti-rheumatoid arthritis activity. This library is of significant value for researching the anti-RA drugs.